X.T.L. Biopharmaceuticals Ltd. - ADR

XTLB

Get informed when a big investor buys or sells

Market Cap$6.88M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
X.T.L. Biopharmaceuticals Ltd. - ADR	-0.8	-	404%	0.7	-1.1

$-1.75

Current Fair Value

159.3% downside

Overvalued by 159.3% based on the discounted cash flow analysis.

Share Statistics

Market cap	$6.88 Million
Enterprise Value	$7.08 Million
Dividend Yield	$- (-)
Earnings per Share	$-68
Beta	0.55
Outstanding Shares	105,163

Return

Return on Equity	404.33%
Return on Assets	-618.67%
Return on Invested Capital	792.91%

Valuation & Multiples

P/E Ratio	-0.83
PEG	8.13
Price to Sales	0.74
Price to Book Ratio	-0.99
Enterprise Value to Revenue	15.69
Enterprise Value to EBIT	-3.51
Enterprise Value to Net Income	-7
Total Debt to Enterprise	0.04
Debt to Equity	-1.06

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

April 29, 2026

EPS Estimate

Average shareholder expectation

Revenue Estimate

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.00000%
Total Calls	-
Total Puts	-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	69.13%▼ 9.25%
Total Invested	$175,378▼ 8.12%
Investors Holding	60%

ESG Score